News

Levels of a protein called glycoprotein nonmetastatic melanoma protein B (GPNMB) are elevated in the blood of people with Parkinson’s disease, indicating the protein may be a biomarker for the neurological disorder, according to a new study. GPNMB also helps to promote the toxic aggregation of alpha-synuclein protein in…

Regular treadmill exercise significantly reduced the aggregation and spread of alpha-synuclein in the brain — a hallmark of Parkinson’s disease — prevented neurodegeneration, and lessened motor deficits in a mouse model of Parkinson’s, a study showed. These benefits were found to be associated with the activation of a receptor…

The activity of a molecular signaling pathway called Delta/Notch in cells of the blood-brain barrier is important for regulating the electrical function of nerve cells, according to a new study using fruit flies. The research, scientists say, could have implications for understanding neurodegenerative diseases like Parkinson’s, which are often…

Sleep disturbances are common in people with diseases marked by alpha-synuclein buildup, but they are especially problematic among Parkinson’s disease patients on dopaminergic medications, a study suggests. Parkinson’s patients tend to have more arousals during sleep and fewer normal sleep cycles than people with isolated rapid eye movement (REM)…

A new Parkinson’s disease mouse model — carrying a common disease-associated mutation in both copies of the LRRK2 gene — recapitulates some motor and behavioral symptoms of the disease, while also showing mitochondrial abnormalities, a study showed. Problems in mitochondria, known as the powerhouses of the body’s cells, are increasingly seen…

Daily oral supplementation with açai berry lessened motor and nonmotor deficits in a mouse model of Parkinson’s disease, a study showed. These benefits were accompanied by a reduction in neuroinflammation, alpha-synuclein protein accumulation, a type of cellular damage called oxidative stress, and dopaminergic neuron loss — all implicated in…

Note: This story was updated Aug. 18, 2022, to reflect researchers awarded The Stanley Fahn Junior Faculty Award will receive a total maximum grant of $300,000 over three years.  The Parkinson’s Foundation announced it is investing $5.7 million across 33 research grants as part of its commitment to speed innovative…

Scientists have created a roadmap of the maturation steps of dopaminergic neurons — the nerve cells progressively lost in Parkinson’s disease — from human stem cells. Their work may help identify potential ways to optimize this process in the lab for new Parkinson’s cell therapies. “Our findings provide valuable…

More people with Parkinson’s disease tend to require higher-level care after experiencing a hip fracture, compared to those who do not have the disease, a study has found. Despite Parkinson’s being a risk factor for hip fracture, most patients do not undergo proper screening or preventive treatment for osteoporosis.

Very high levels of levodopa — a compound commonly prescribed to treat Parkinson’s disease — were detected in some over-the-counter supplements with extracts from Mucuna pruriens, a type of bean that naturally contains levodopa, a study has found. In many of the tested supplements, the amount of levodopa…